Sit Investment Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Sit Investment Associates's AMGN Position: Q2 2026 in Review
Sit Investment Associates reduced its Amgen (AMGN) stake by 43% in Q2 2026, selling an estimated $59.9K and leaving 235 shares worth $85K. The position accounts for ﹤0.01% of the portfolio, ranked #479.
Sit Investment Associates first reported a position in AMGN in Q2 2018 and has held it in 25 quarters since. The position peaked at $20.5M in Q3 2018. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Sit Investment Associates held 235 shares of Amgen worth $85K as of Q2 2026.
- Sit Investment Associates sold 175 Amgen shares in Q2 2026, an estimated $59.9K.
- Amgen made up ﹤0.01% of Sit Investment Associates's portfolio in Q2 2026, its #479 holding.
- Sit Investment Associates first reported a position in Amgen in Q2 2018 and has held it in 25 quarters since.
- Sit Investment Associates's Amgen position peaked at $20.5M in Q3 2018.
- 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.